Advances in alcoholic liver disease

Current Gastroenterology Reports

Volumn 13, Issue 1, 2011, Pages 56-64

  Beier, Juliane I ^a,b   Arteel, Gavin E ^a,b   McClain, Craig J ^a,b,c  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alcoholic liver disease; Coagulation; Ethanol; Fibrosis cirrhosis; Inflammation; Lipopolysaccharide; Nutrition; Oxidative stress; Stress kinases

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CYTOKINE; ENDOTOXIN; FIBRIN; NEOMYCIN; OXANDROLONE; PLACEBO; POLAPREZINC; PREDNISONE; THROMBIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; ZINC;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; CELL ACTIVATION; CELL DAMAGE; CHEMICAL MODIFICATION; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE ACTIVITY; DISEASE COURSE; EXTRACELLULAR MATRIX; FIBRIN METABOLISM; FOOD INTAKE; HUMAN; LIVER FIBROSIS; MALNUTRITION; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STELLATE CELL; ZINC DEFICIENCY; ZINC METABOLISM;

BLOOD COAGULATION; CYTOKINES; FIBRIN; GASTROINTESTINAL TRACT; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES, ALCOHOLIC; MALNUTRITION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; ZINC;

EID: 79551523970     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-010-0157-5     Document Type: Article

References (97)

1. JM McCord I Fridovich 1969 Superoxide dismutase: an enzymatic function of erythrocuprein (hemocuprein) J Biol Chem 244 6049 6055 1:CAS:528:DyaE3cXmsVU%3D 5389100
2. Sies H: Oxidative stress: introductory remarks. In Oxidative Stress. Edited by Sies H. London:Academic Press; 1985:1-8.
3. NR Di Luzio 1966 A mechanism of the acute ethanol-induced fatty liver and the modification of liver injury by antioxidants Lab Invest 15 50 63
4. AJ Patek Jr 1979 Alcohol, malnutrition, and alcoholic cirrhosis Am J Clin Nutr 32 6 1304 1312 1:CAS:528:DyaE1MXks12gtrs%3D 375714
5. L Bujanda 2000 The effects of alcohol consumption upon the gastrointestinal tract Am J Gastroenterol 95 12 3374 3382 1:CAS:528: DC%2BD3MXmtVWnug%3D%3D 10.1111/j.1572-0241.2000.03347.x 11151864
6. CS Lieber 2000 Alcohol: its metabolism and interaction with nutrients Annu Rev Nutr 20 395 430 1:CAS:528:DC%2BD3cXmsVKlsro%3D 10.1146/annurev.nutr.20. 1.395 10940340
7. GE Arteel 2003 Oxidants and antioxidants in alcohol-induced liver disease Gastroenterology 124 3 778 790 1:CAS:528:DC%2BD3sXisVKnt74%3D 10.1053/gast.2003.50087 12612915 (Pubitemid 36268494)
8. H Kono GE Arteel I Rusyn, et al. 2001 Ebselen prevents early alcohol-induced liver injury in rats Free Radic Biol Med 30 4 403 411 1:CAS:528:DC%2BD3MXhtFegsbg%3D 10.1016/S0891-5849(00)00490-1 11182296 (Pubitemid 32155539)
9. H Kono I Rusyn T Uesugi, et al. 2001 Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat Am J Physiol Gastrointest Liver Physiol 280 5 G1005 G1012 1:CAS:528: DC%2BD3MXjsVaht7w%3D 11292610
10. H Kono I Rusyn H Connor, et al. 2000 Allopurinol prevents early alcohol-induced liver injury in rats J Pharmacol Exp Therapeut 293 1 296 303 1:CAS:528:DC%2BD3cXkvFGhurg%3D
11. H Sies 1986 Biochemistry of oxidative stress Angew Chem Int Ed Engl 25 1058 1071 10.1002/anie.198610581
12. Jones DP: The role of oxygen concentration in oxidative stress: hypoxic and hyperoxic models. In Oxidative Stress. Edited by Sies H. London:Academic Press; 1985:151-195.
13. DL Tribble DP Jones 1990 Oxygen dependence of oxidative stress: Rate of NADPH supply for maintaining the GSH pool during hypoxia Biochem Pharmacol 39 4 729 736 1:CAS:528:DyaK3cXhsFKju7Y%3D 10.1016/0006-2952(90)90152-B 2306281 (Pubitemid 20055768)
14. S Shaw E Jayatilleke CS Lieber 1988 Lipid peroxidation as a mechanism of alcoholic liver injury: role of iron mobilization and microsomal induction Alcohol 5 135 140 1:CAS:528:DyaL1cXktVahu7o%3D 10.1016/0741-8329(88)90010-9 3134909 (Pubitemid 19270495)
15. F Bardag-Gorce QX Yuan J Li, et al. 2000 The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol Biochem Biophys Res Commun 279 1 23 29 1:CAS:528:DC%2BD3cXosFGgtr4%3D 10.1006/bbrc.2000.3889 11112412
16. TM Donohue Jr 2002 The ubiquitin-proteasome system and its role in ethanol-induced disorders Addict Biol 7 1 15 28 1:CAS:528:DC%2BD38XhsFKqtrs%3D 10.1080/135562101200100562 11900619 (Pubitemid 34087904)
17. W Droge 2002 Free radicals in the physiological control of cell function Physiol Rev 82 1 47 95 1:CAS:528:DC%2BD38XovFSisw%3D%3D 11773609
18. HJ Forman M Torres 2001 Redox signaling in macrophages Mol Aspects Med 22 4-5 189 216 1:STN:280:DC%2BD3MnmvVSntg%3D%3D 10.1016/S0098-2997(01)00010-3 11679166 (Pubitemid 33000522)
19. H Kamata H Hirata 1999 Redox regulation of cellular signalling Cell Signal 11 1 1 14 1:CAS:528:DyaK1MXhvF2m 10.1016/S0898-6568(98)00037-0 10206339 (Pubitemid 28546635)
20. RG Allen M Tresini 2000 Oxidative stress and gene regulation Free Radic Biol Med 28 3 463 499 1:CAS:528:DC%2BD3cXhsVant74%3D 10.1016/S0891-5849(99) 00242-7 10699758 (Pubitemid 30110662)
21. G Ermak KJ Davies 2002 Calcium and oxidative stress: from cell signaling to cell death Mol Immunol 38 10 713 721 1:CAS:528:DC%2BD38XhtFCks78%3D 10.1016/S0161-5890(01)00108-0 11841831 (Pubitemid 34158874)
22. YJ Suzuki HJ Forman A Sevanian 1997 Oxidants as stimulators of signal transduction Free Radic Biol Med 22 1-2 269 285 1:CAS:528:DyaK28XnsVGju70%3D 10.1016/S0891-5849(96)00275-4 8958153
23. CT D'Angio JN Finkelstein 2000 Oxygen regulation of gene expression: a study in opposites Mol Genet Metab 71 1-2 371 380 10.1006/mgme.2000.3074 11001829
24. JB Hoek JG Pastorino 2002 Ethanol, oxidative stress, and cytokine-induced liver cell injury Alcohol 27 1 63 68 1:CAS:528:DC%2BD38Xktlymtro%3D 10.1016/S0741-8329(02)00215-X 12062639 (Pubitemid 34626486)
25. G Szabo S Bala 2010 Alcoholic liver disease and the gut-liver axis World J Gastroenterol 16 11 1321 1329 1:CAS:528:DC%2BC3cXjvVKhsrY%3D 10.3748/wjg.v16.i11.1321 20238398
26. P Mandrekar G Szabo 2009 Signalling pathways in alcohol-induced liver inflammation J Hepatol 50 6 1258 1266 1:CAS:528:DC%2BD1MXlslWms7g%3D 10.1016/j.jhep.2009.03.007 19398236
27. E Mezey JJ Potter L Rennie-Tankersley, et al. 2004 A randomized placebo controlled trial of vitamin E for alcoholic hepatitis J Hepatol 40 1 40 46 1:CAS:528:DC%2BD3sXps1Ogsb4%3D 10.1016/S0168-8278(03)00476-8 14672612 In this study, the authors showed that a relatively high dose of vitamin E (1000 U) had no protective effect in patients with alcoholic hepatitis. The effectiveness of vitamin E alone was brought into question from the results of this study (Pubitemid 38064711)
28. S Stewart M Prince M Bassendine, et al. 2007 A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis J Hepatol 47 2 277 283 1:CAS:528:DC%2BD2sXnsFKgurk%3D 10.1016/j.jhep.2007.03.027 17532088 The authors of this study used a "cocktail" of antioxidants in patients with alcoholic hepatitis and did not observe any protective effect (Pubitemid 47021256)
29. V Purohit JC Bode C Bode, et al. 2008 Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium Alcohol 42 5 349 361 1:CAS:528:DC%2BD1cXosVOksL0%3D 10.1016/j.alcohol.2008.03.131 18504085
30. T Gustot A Lemmers C Moreno, et al. 2006 Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver Hepatology 43 5 989 1000 1:CAS:528:DC%2BD28XkvFGmt7Y%3D 10.1002/hep.21138 16628628 (Pubitemid 43724624)
31. TD Luckey JA Reyniers P Gyorgy, et al. 1954 Germfree animals and liver necrosis Ann N Y Acad Sci 57 6 932 935 1:STN:280:DyaG2c7gtFCrtQ%3D%3D 10.1111/j.1749-6632.1954.tb36472.x 13181325
32. AM Rutenburg E Sonnenblick I Koven, et al. 1957 The role of intestinal bacteria in the development of dietary cirrhosis in rats J Exp Med 106 1 1 14 1:CAS:528:DyaG2sXpt1aitw%3D%3D 10.1084/jem.106.1.1 13439110
33. SA Broitman LS Gottlieb N Zamcheck 1964 Influence of Neomycin and Ingested Endotoxin in the Pathogenesis of Choline Deficiency Cirrhosis in the Adult Rat J Exp Med 119 633 642 1:STN:280:DyaF2c7gvFSgtQ%3D%3D 10.1084/jem.119.4.633 14151103
34. JP Nolan 1979 The contribution of gut-derived endotoxins to liver injury Yale J Biol Med 52 1 127 133 1:CAS:528:DyaE1MXltVKjtb0%3D 377823
35. GJ Gabuzda 1962 Hepatic coma: clinical considerations, pathogenesis, and management Adv Intern Med 11 11 73 1:CAS:528:DyaF3sXhtVKmsQ%3D%3D 13896105
36. L Zieve 1966 Pathogenesis of hepatic coma Arch Intern Med 118 3 211 223 1:STN:280:DyaF287nt1Omtg%3D%3D 10.1001/archinte.118.3.211 5329903
37. McClain CJ, Zieve L: Portal Systemic Encephalopathy: Recognition and Variations. In Problems in Liver Diseases. Edited by Davidson CS. New York: Stratton Intercontinental Medical Book Corp.; 1979:162-172.
38. Y Adachi LE Moore BU Bradford, et al. 1995 Antibiotics prevent liver injury in rats following long-term exposure to ethanol Gastroenterology 108 1 218 224 1:CAS:528:DyaK2MXjs12lurw%3D 10.1016/0016-5085(95)90027-6 7806045
39. A Keshavarzian S Choudhary EW Holmes, et al. 2001 Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats J Pharmacol Exp Ther 299 2 442 448 1:CAS:528:DC%2BD3MXnvV2qsb4%3D 11602653
40. AA Nanji U Khettry SM Sadrzadeh 1994 Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease) Proc Soc Exp Biol Med 205 3 243 247 1:CAS:528:DyaK2cXisVWlt7s%3D 8171045
41. CJ McClain Z Song SS Barve, et al. 2004 Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease Am J Physiol Gastrointest Liver Physiol 287 3 G497 502 1:CAS:528: DC%2BD2cXnvVeju7k%3D 10.1152/ajpgi.00171.2004 15331349 (Pubitemid 39096613)
42. Y Iimuro RM Gallucci MI Luster, et al. 1997 Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat Hepatology 26 6 1530 1537 1:CAS:528:DyaK1cXntFCi 10.1002/hep.510260621 9397994
43. M Yin MD Wheeler H Kono, et al. 1999 Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice Gastroenterology 117 4 942 952 1:CAS:528:DyaK1MXmvVWms7c%3D 10.1016/S0016-5085(99)70354-9 10500078 (Pubitemid 29468238)
44. R Honchel MB Ray L Marsano, et al. 1992 Tumor necrosis factor in alcohol enhanced endotoxin liver injury Alcohol Clin Exp Res 16 4 665 669 1:CAS:528:DyaK3sXhslyiuw%3D%3D 10.1111/j.1530-0277.1992.tb00656.x 1530127
45. G Szabo S Bala 2010 Alcoholic liver disease and the gut-liver axis World J Gastroenterol 16 11 1321 1329 1:CAS:528:DC%2BC3cXjvVKhsrY%3D 10.3748/wjg.v16.i11.1321 20238398 The authors review the interactions of gut flora, gut-derived toxins, and liver injury, including the role of tolls in liver injury
46. CJ McClain DA Cohen 1989 Increased tumor necrosis factor production by monocytes in alcoholic hepatitis Hepatology 9 3 349 351 1:STN:280: DyaL1M7lsVeitA%3D%3D 10.1002/hep.1840090302 2920991 (Pubitemid 19074964)
47. A Khoruts L Stahnke CJ McClain, et al. 1991 Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients Hepatology 13 2 267 276 1:STN:280:DyaK3M7jvFSmtQ%3D%3D 10.1002/hep.1840130211 1995437
48. S Naveau S Chollet-Martin S Dharancy, et al. 2004 A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis Hepatology 39 5 1390 1397 1:CAS:528:DC%2BD2cXks1Sjurg%3D 10.1002/hep.20206 15122768 (Pubitemid 38569061)
49. NC Boetticher CJ Peine P Kwo, et al. 2008 A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis Gastroenterology 135 6 1953 1960 1:CAS:528:DC%2BD1MXht1ertrw%3D 10.1053/j.gastro.2008.08.057 18848937
50. E Akriviadis R Botla W Briggs, et al. 2000 Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial Gastroenterology 119 1637 1648 1:CAS:528: DC%2BD3MXhtlKmsg%3D%3D 10.1053/gast.2000.20189 11113085
51. BK De S Gangopadhyay D Dutta SD Baksi A Pani P Ghosh 2009 Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial World J Gastroenterol 15 13 1613 9 1:CAS:528:DC%2BD1MXpsFCgsrY%3D 10.3748/wjg.15.1613 19340904 This article describes a randomized study that showed improved survival and renoprotection in alcoholic hepatitis with pentoxifylline compared to prednisolone
52. C Mendenhall GA Roselle P Gartside, et al. 1995 Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies Alcohol Clin Exp Res 19 3 635 641 1:STN:280:DyaK28%2FivVeksw%3D%3D 10.1111/j.1530-0277.1995.tb01560.x 7573786
53. CL Mendenhall S Anderson RE Weesner, et al. 1984 Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis Am J Med 76 2 211 222 1:STN:280:DyaL2c7isFertA%3D%3D 10.1016/0002-9343(84)90776-9 6421159 (Pubitemid 14157835)
54. CL Mendenhall TE Moritz GA Roselle, et al. 1995 Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275 JPEN J Parenter Enteral Nutr 19 4 258 265 1:STN:280:DyaK287jtFajug%3D%3D 10.1177/0148607195019004258 8523623
55. CL Mendenhall T Tosch RE Weesner, et al. 1986 VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition Am J Clin Nutr 43 2 213 218 1:STN:280:DyaL287islWisA%3D%3D 3080866
56. CL Mendenhall TE Moritz GA Roselle, et al. 1993 A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study Hepatology 17 4 564 576 1:STN:280:DyaK3s3jvFWjtg%3D%3D 10.1002/hep.1840170407 8477961
57. E Cabre P Rodriguez-Iglesias J Caballeria, et al. 2000 Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial Hepatology 32 1 36 42 1:CAS:528:DC%2BD3cXltFWgsrc%3D 10.1053/jhep.2000.8627 10869286
58. LD Plank EJ Gane S Peng, et al. 2008 Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial Hepatology 48 2 557 566 10.1002/hep.22367 18627001 This article documents the importance of nighttime snacks in maintaining muscle mass in cirrhotics. Patients with cirrhosis can transition to a "starvation" state overnight
59. YJ Kang Z Zhou 2005 Zinc prevention and treatment of alcoholic liver disease Mol Aspects Med 26 4-5 391 404 1:CAS:528:DC%2BD2MXpslygur0%3D 10.1016/j.mam.2005.07.002 16099027 (Pubitemid 41225361)
60. CJ McClain DR Antonow DA Cohen, et al. 1986 Zinc metabolism in alcoholic liver disease Alcohol Clin Exp Res 10 6 582 589 1:CAS:528:DyaL2sXmt1aqtg%3D%3D 10.1111/j.1530-0277.1986.tb05149.x 3544908
61. Z Zhou X Kang Y Jiang, et al. 2007 Preservation of hepatocyte nuclear factor-4alpha is associated with zinc protection against TNF-alpha hepatotoxicity in mice Exp Biol Med (Maywood) 232 5 622 628 1:CAS:528: DC%2BD2sXmt1Oqsr0%3D
62. M Shea-Budgell M Dojka M Nimmo, et al. 2006 Marginal zinc deficiency increased the susceptibility to acute lipopolysaccharide-induced liver injury in rats Exp Biol Med (Maywood) 231 5 553 558 1:CAS:528:DC%2BD28XktlCqs7Y%3D
63. JC Lambert Z Zhou YJ Kang 2003 Suppression of Fas-mediated signaling pathway is involved in zinc inhibition of ethanol-induced liver apoptosis Exp Biol Med (Maywood) 228 4 406 412 1:CAS:528:DC%2BD3sXls1Wkt7s%3D
64. W Zhong CJ McClain M Cave, et al. 2010 The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction Am J Physiol Gastrointest Liver Physiol 298 5 G625 633 1:CAS:528:DC%2BC3cXmtlWjtLo%3D 10.1152/ajpgi.00350.2009 20167873
65. PC Joshi A Mehta WS Jabber, et al. 2009 Zinc deficiency mediates alcohol-induced alveolar epithelial and macrophage dysfunction in rats Am J Respir Cell Mol Biol 41 2 207 216 1:CAS:528:DC%2BD1MXps1elt7c%3D 10.1165/rcmb.2008-0209OC 19109243
66. M Takahashi H Saito M Higashimoto, et al. 2007 Possible inhibitory effect of oral zinc supplementation on hepatic fibrosis through downregulation of TIMP-1: A pilot study Hepatol Res 37 6 405 409 1:CAS:528:DC%2BD2sXotVCgsrw%3D 10.1111/j.1872-034X.2007.00065.x 17539814 (Pubitemid 46915784)
67. PG Northup V Sundaram MB Fallon, et al. 2008 Hypercoagulation and thrombophilia in liver disease J Thromb Haemost 6 1 2 9 1:STN:280: DC%2BD1c7gtF2nug%3D%3D 17892532 This review is a state-of-the-art proceeding from the first Coagulopathy in Liver Disease conference held in Charlottesville, VA, USA. All authors presented at the conference on a separate topic concerning hypercoagulation in liver disease
68. K Kolev R Machovich 2003 Molecular and cellular modulation of fibrinolysis Thromb Haemost 89 4 610 621 1:CAS:528:DC%2BD3sXjtl2nsLY%3D 12669114
69. GE Arteel 2008 New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury J Gastroenterol Hepatol 23 Suppl 1 S54 59 1:CAS:528:DC%2BD1cXkslKgsbc%3D 10.1111/j.1440-1746.2007.05285.x 18336665 (Pubitemid 351389031)
70. JI Beier L Guo C Von Montfort, et al. 2008 New role of resistin in lipopolysaccharide-induced liver damage in mice J Pharmacol Exp Ther 325 3 801 808 1:CAS:528:DC%2BD1cXmsVOrtr0%3D 10.1124/jpet.108.136721 18339969 (Pubitemid 351724330)
71. JI Beier JP Luyendyk L Guo, et al. 2009 Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice Hepatology 49 5 1545 1553 1:CAS:528: DC%2BD1MXlslKmurg%3D 10.1002/hep.22847 19291788
72. I Bergheim L Guo MA Davis, et al. 2006 Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1 Gastroenterology 130 7 2099 2112 1:CAS:528:DC%2BD28XntVWit70%3D 10.1053/j.gastro.2006.03.020 16762632 This article is the first to show that steatosis due to acute or chronic enteral alcohol exposure was blunted by blocking PAI-1 induction, independent of AMPK activation (Pubitemid 43816952)
73. I Bergheim L Guo MA Davis, et al. 2006 Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis J Pharmacol Exp Ther 316 2 592 600 1:CAS:528:DC%2BD28XhtlWqsLk%3D 10.1124/jpet.105.095042 16221737 (Pubitemid 43130985)
74. PE Ganey JP Luyendyk JF Maddox, et al. 2004 Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor Chem Biol Interact 150 1 35 51 1:CAS:528:DC%2BD2cXptFOntbw%3D 10.1016/j.cbi.2004.09.002 15522260 (Pubitemid 39441294)
75. JM Pearson AE Schultze KA Schwartz, et al. 1996 The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat J Pharmacol Exp Ther 278 1 378 383 1:CAS:528:DyaK28XktlGgsbo%3D 8764373
76. KM Hodivala-Dilke AR Reynolds LE Reynolds 2003 Integrins in angiogenesis: multitalented molecules in a balancing act Cell Tissue Res 314 1 131 144 1:CAS:528:DC%2BD3sXos1Cmu7c%3D 10.1007/s00441-003-0774-5 13680353 (Pubitemid 37409919)
77. HF Zhou HW Chan SA Wickline, et al. 2009 Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice FASEB J 23 9 2978 2985 1:CAS:528:DC%2BD1MXhtFagsrjP 10.1096/fj.09-129874 19376816
78. EY Dimova T Kietzmann 2008 Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver Thromb Haemost 100 6 992 1006 1:CAS:528:DC%2BD1MXptVyisA%3D%3D 19132222
79. C Tran-Thang J Fasel-Felley G Pralong, et al. 1989 Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis Thromb Haemost 62 2 651 653 1:STN:280:DyaK3c%2FkvFyruw%3D%3D 2510345
80. D Seth PJ Hogg MD Gorrell, et al. 2008 Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease J Hepatol 48 4 614 627 1:CAS:528:DC%2BD1cXjtVCgs70%3D 10.1016/j.jhep.2007.12.015 18289715
81. T Lisman SH Caldwell AK Burroughs, et al. 2010 Hemostasis and thrombosis in patients with liver disease: the ups and downs J Hepatol 53 2 362 371 10.1016/j.jhep.2010.01.042 20546962
82. D Schuppan M Ruehl R Somasundaram, et al. 2001 Matrix as a modulator of hepatic fibrogenesis Semin Liver Dis 21 3 351 372 1:CAS:528:DC%2BD3MXnvVant70%3D 10.1055/s-2001-17556 11586465 (Pubitemid 32923765)
83. D Cassiman L Libbrecht V Desmet, et al. 2002 Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers J Hepatol 36 2 200 209 10.1016/S0168-8278(01)00260-4 11830331 (Pubitemid 34146426)
84. M Zeisberg C Yang M Martino, et al. 2007 Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition J Biol Chem 282 32 23337 23347 1:CAS:528:DC%2BD2sXosVyrsb8%3D 10.1074/jbc.M700194200 17562716 (Pubitemid 47311952)
85. H Robertson JA Kirby WW Yip, et al. 2007 Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis Hepatology 45 4 977 981 1:CAS:528:DC%2BD2sXltlWit7o%3D 10.1002/hep.21624 17393507 (Pubitemid 46631566)
86. A Omenetti A Porrello Y Jung, et al. 2008 Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans J Clin Invest 118 10 3331 3342 1:CAS:528:DC%2BD1cXht1ChsrrO 18802480
87. RG Gieling AD Burt DA Mann 2008 Fibrosis and cirrhosis reversibility - molecular mechanisms Clin Liver Dis 12 4 915 937 10.1016/j.cld.2008.07.001 18984474 xi
88. T Poynard J McHutchison M Manns, et al. 2002 Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C Gastroenterology 122 5 1303 1313 1:CAS:528:DC%2BD38Xkt1Cru74%3D 10.1053/gast.2002.33023 11984517 In this seminal work, the authors showed that "end-stage" liver disease may revert in some patients, if the underlying cause is effectively treated. This work sparked great interest in identifying new therapies to accelerate reversion of fibrosis/cirrhosis in experimental models and in patients
89. JP Iredale RC Benyon J Pickering, et al. 1998 Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors J Clin Invest 102 3 538 549 1:CAS:528:DyaK1cXlt1egur8%3D 10.1172/JCI1018 9691091
90. X Liu H Hu JQ Yin 2006 Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis Liver Int 26 1 8 22 10.1111/j.1478-3231.2005.01192.x 16420505
91. Y Iimuro DA Brenner 2008 Matrix metalloproteinase gene delivery for liver fibrosis Pharm Res 25 2 249 258 1:CAS:528:DC%2BD1cXitVejt70%3D 10.1007/s11095-007-9311-7 17577645
92. RC Benyon MJ Arthur 2001 Extracellular matrix degradation and the role of hepatic stellate cells Semin Liver Dis 21 3 373 384 1:CAS:528: DC%2BD3MXnvVant7o%3D 10.1055/s-2001-17552 11586466 (Pubitemid 32923766)
93. H Tsukamoto W Horne S Kamimura, et al. 1995 Experimental liver cirrhosis induced by alcohol and iron J Clin Invest 96 1 620 630 1:CAS:528: DyaK2MXmslyqtrc%3D 10.1172/JCI118077 7615836
94. JP Iredale 2007 Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ J Clin Invest 117 3 539 548 1:CAS:528:DC%2BD2sXis12htr4%3D 10.1172/JCI30542 17332881 (Pubitemid 46348508)
95. S Lotersztajn B Julien F Teixeira-Clerc, et al. 2005 Hepatic fibrosis: molecular mechanisms and drug targets Annu Rev Pharmacol Toxicol 45 605 628 1:CAS:528:DC%2BD2MXisVWjtLc%3D 10.1146/annurev.pharmtox.45.120403.095906 15471534 (Pubitemid 40261819)
96. D Lebrec D Thabut F Oberti, et al. 2010 Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis Gastroenterology 138 5 1755 1762 1:CAS:528:DC%2BC3cXmsFyktL8%3D 10.1053/j.gastro.2010.01.040 20102716
97. A Louvet E Diaz S Dharancy, et al. 2008 Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids J Hepatol 48 3 465 470 1:CAS:528:DC%2BD1cXhsl2ms74%3D 10.1016/j.jhep.2007.10.010 18164508